Advertisement
Screener

VBI Vaccines Inc/BC Research and Development Expense

VBI Vaccines Inc/BC Research and Development Expense

VBI Vaccines Inc/BC reported Research and Development Expense of $2.57 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2024-05-15

  • VBI Vaccines Inc/BC research and development expense for the quarter ending 2024-03-31 was $2.57M, a 18.41% decline year-over-year.
  • VBI Vaccines Inc/BC research and development expense for the quarter ending 2023-12-31 was $1.37M, a 45.67% decline year-over-year.
  • VBI Vaccines Inc/BC research and development expense for the quarter ending 2023-09-30 was $1.53M, a 69.26% decline year-over-year.
  • VBI Vaccines Inc/BC research and development expense for the quarter ending 2023-06-30 was $3.29M, a 41.66% decline year-over-year.
  • VBI Vaccines Inc/BC research and development expense for fiscal 2023 was $9.34M, a 39.75% decline from fiscal 2022.
  • VBI Vaccines Inc/BC research and development expense for fiscal 2022 was $15.51M, a 20.72% decline from fiscal 2021.
  • VBI Vaccines Inc/BC research and development expense for fiscal 2021 was $19.56M, a 31.62% increase from fiscal 2020.
  • VBI Vaccines Inc/BC research and development expense for fiscal 2020 was $14.86M, a 43.57% decline from fiscal 2019.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2024-03-31$2.57M
10-Q · filed 2024-05-15
$3.94M
derived: sum of 2 quarters · filed 2024-05-15
$5.47M
derived: sum of 3 quarters · filed 2024-05-15
$8.76M
derived: sum of 4 quarters · filed 2024-05-15
2023-12-31$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$2.90M
derived: sum of 2 quarters · filed 2024-04-16
$6.19M
derived: sum of 3 quarters · filed 2024-04-16
$9.34M
10-K · filed 2024-04-16
2023-09-30$1.53M
10-Q · filed 2023-11-14
$4.82M
derived: sum of 2 quarters · filed 2023-11-14
$7.97M
10-Q · filed 2023-11-14
$10.49M
derived: sum of 4 quarters · filed 2024-05-15
2023-06-30$3.29M
10-Q · filed 2023-08-14
$6.45M
10-Q · filed 2023-08-14
$8.96M
derived: sum of 3 quarters · filed 2024-05-15
$13.94M
derived: sum of 4 quarters · filed 2024-05-15
2023-03-31$3.15M
10-Q · filed 2024-05-15
$5.67M
derived: sum of 2 quarters · filed 2024-05-15
$10.65M
derived: sum of 3 quarters · filed 2024-05-15
$16.30M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$7.50M
derived: sum of 2 quarters · filed 2024-04-16
$13.14M
derived: sum of 3 quarters · filed 2024-04-16
$15.51M
10-K · filed 2024-04-16
2022-09-30$4.98M
10-Q · filed 2023-11-14
$10.63M
derived: sum of 2 quarters · filed 2023-11-14
$12.99M
10-Q · filed 2023-11-14
$18.15M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$5.64M
10-Q · filed 2023-08-14
$8.01M
10-Q · filed 2023-08-14
$13.17M
derived: sum of 3 quarters · filed 2023-08-14
$16.14M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$2.36M
10-Q · filed 2023-05-15
$7.53M
derived: sum of 2 quarters · filed 2023-05-15
$10.50M
derived: sum of 3 quarters · filed 2023-05-15
$15.08M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$5.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
$8.14M
derived: sum of 2 quarters · filed 2023-03-13
$12.72M
derived: sum of 3 quarters · filed 2023-03-13
$19.56M
10-K · filed 2023-03-13
2021-09-30$2.97M
10-Q · filed 2022-11-10
$7.55M
derived: sum of 2 quarters · filed 2022-11-10
$14.39M
10-Q · filed 2022-11-10
$19.22M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$4.58M
10-Q · filed 2022-08-08
$11.42M
10-Q · filed 2022-08-08
$16.25M
derived: sum of 3 quarters · filed 2022-08-08
$20.72M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$6.84M
10-Q · filed 2022-05-09
$11.66M
derived: sum of 2 quarters · filed 2022-05-09
$16.14M
derived: sum of 3 quarters · filed 2022-05-09
$18.51M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$4.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07
$9.30M
derived: sum of 2 quarters · filed 2022-03-07
$11.67M
derived: sum of 3 quarters · filed 2022-03-07
$14.86M
10-K · filed 2022-03-07
2020-09-30$4.48M
10-Q · filed 2021-11-08
$6.84M
derived: sum of 2 quarters · filed 2021-11-08
$10.04M
10-Q · filed 2021-11-08
$14.38M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$2.37M
10-Q · filed 2021-08-02
$5.56M
10-Q · filed 2021-08-02
$9.90M
derived: sum of 3 quarters · filed 2021-08-02
$15.30M
derived: sum of 4 quarters · filed 2021-08-02
2020-03-31$3.19M
10-Q · filed 2021-05-10
$7.54M
derived: sum of 2 quarters · filed 2021-05-10
$12.94M
derived: sum of 3 quarters · filed 2021-05-10
$20.30M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
$9.74M
derived: sum of 2 quarters · filed 2021-03-02
$17.11M
derived: sum of 3 quarters · filed 2021-03-02
$26.33M
10-K · filed 2021-03-02
2019-09-30$5.40M
10-Q · filed 2020-11-02
$12.76M
derived: sum of 2 quarters · filed 2020-11-02
$21.99M
10-Q · filed 2020-11-02
$31.88M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30$7.36M
10-Q · filed 2020-07-31
$16.59M
10-Q · filed 2020-07-31
$26.48M
derived: sum of 3 quarters · filed 2020-07-31
$36.99M
derived: sum of 4 quarters · filed 2020-07-31
2019-03-31$9.04M
10-Q · filed 2020-05-06
$9.23M
10-Q · filed 2019-05-01
$19.12M
derived: sum of 2 quarters · filed 2020-05-06
$29.63M
derived: sum of 3 quarters · filed 2020-05-06
$40.54M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$10.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$20.59M
derived: sum of 2 quarters · filed 2020-03-05
$31.50M
derived: sum of 3 quarters · filed 2020-03-05
$38.47M
10-K · filed 2020-03-05
2018-09-30$10.51M
10-Q · filed 2019-11-06
$21.42M
derived: sum of 2 quarters · filed 2019-11-06
$28.39M
10-Q · filed 2019-11-06
$34.92M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$10.91M
10-Q · filed 2019-08-09
$17.88M
10-Q · filed 2019-08-09
$24.41M
derived: sum of 3 quarters · filed 2019-08-09
$29.61M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$6.96M
10-Q · filed 2019-05-01
$13.49M
derived: sum of 2 quarters · filed 2019-05-01
$18.70M
derived: sum of 3 quarters · filed 2019-05-01
$23.23M
derived: sum of 4 quarters · filed 2019-05-01
2017-12-31$6.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$11.74M
derived: sum of 2 quarters · filed 2019-02-25
$16.26M
derived: sum of 3 quarters · filed 2019-02-25
$20.92M
10-K · filed 2019-02-25
2017-09-30$5.21M
10-Q · filed 2018-11-09
$9.73M
derived: sum of 2 quarters · filed 2018-11-09
$14.39M
10-Q · filed 2018-11-09
$18.61M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$4.53M
10-Q · filed 2018-07-26
$9.18M
10-Q · filed 2018-07-26
$13.40M
derived: sum of 3 quarters · filed 2018-07-26
$16.77M
derived: sum of 4 quarters · filed 2018-07-26
2017-03-31$4.65M
10-Q · filed 2018-05-01
$8.87M
derived: sum of 2 quarters · filed 2018-05-01
$12.24M
derived: sum of 3 quarters · filed 2018-05-01
$14.37M
derived: sum of 4 quarters · filed 2018-05-01
2016-12-31$4.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$7.59M
derived: sum of 2 quarters · filed 2018-02-26
$9.71M
derived: sum of 3 quarters · filed 2018-02-26
$9.97M
10-K · filed 2018-02-26
2016-09-30$3.37M
10-Q · filed 2017-11-13
$5.49M
derived: sum of 2 quarters · filed 2017-11-13
$5.75M
10-Q · filed 2017-11-13
2016-06-30$2.12M
10-Q · filed 2017-07-31
$2.38M
10-Q · filed 2017-07-31
2016-03-31$254.00K
10-Q · filed 2017-05-15
2015-12-31$14.12M
10-K · filed 2018-02-26